PharmaSeq is a genomics company that has developed the world's first light-powered microtransponders and nanotransponders for performing nucleic acid-based assays. It is a biotechnology company with corporate headquarters and research and development facilities near Princeton, N.J. The company has eight United States patents for microtransponder-based assays and technology and more patents pending. PharmaSeq's strategy is to apply microtransponder technology to DNA probe diagnostics, single nucleotide polymorphism detection and proteomics.
Partial Data by Infogroup (c) 2024. All rights reserved.
Partial Data by Foursquare.